IW
GILD icon

Imprint Wealth’s Gilead Sciences GILD Stock Holding History

Imprint Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.68K Hold
45
– – 0.02% 165
2026
Q1 		$6.27K Hold
45
– – 0.03% 152
2025
Q4 		$5.52K Sell
45
-97
-68% -$11.8K 0.03% 185
2025
Q3 		$15.8K Buy
+142
New +$16.1K 0.05% 148
2024
Q1 		$266K Buy
3,648
+301
+9% +$23.1K 0.06% 246
2023
Q4 		$271K Buy
3,347
+576
+21% +$44.8K 0.22% 128
2023
Q3 		$208K Buy
+2,771
New +$213K 0.18% 141

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Imprint Wealth's GILD Position: Q2 2026 in Review

Imprint Wealth held its Gilead Sciences (GILD) position steady in Q2 2026 at 45 shares worth $5.68K. The position accounts for 0.02% of the portfolio, ranked #165.

Imprint Wealth first reported a position in GILD in Q3 2023 and has held it in 7 quarters since. The position peaked at $271K in Q4 2023. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Imprint Wealth held 45 shares of Gilead Sciences worth $5.68K as of Q2 2026.
  • Imprint Wealth left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.02% of Imprint Wealth's portfolio in Q2 2026, its #165 holding.
  • Imprint Wealth first reported a position in Gilead Sciences in Q3 2023 and has held it in 7 quarters since.
  • Imprint Wealth's Gilead Sciences position peaked at $271K in Q4 2023.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Imprint Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.